Oyster Point Pharma, Inc. Income (Loss) from Continuing Operations, Per Basic and Diluted Share
Oyster Point Pharma, Inc. reported Income (Loss) from Continuing Operations, Per Basic and Diluted Share of -$0.86 per share for the 3-month period ending 2020-12-31, per its 10-K filed 2021-02-18.
Discontinued › Income Statement › Other Income
us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare · last filed 2021-02-18
- Oyster Point Pharma, Inc. income (loss) from continuing operations, per basic and diluted share for the quarter ending 2020-12-31 was -$0.86.
- Oyster Point Pharma, Inc. income (loss) from continuing operations, per basic and diluted share for the quarter ending 2020-09-30 was -$0.63.
- Oyster Point Pharma, Inc. income (loss) from continuing operations, per basic and diluted share for the quarter ending 2020-06-30 was -$0.66.
- Oyster Point Pharma, Inc. income (loss) from continuing operations, per basic and diluted share for the quarter ending 2020-03-31 was -$0.77.
| Period end | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 3 month |
|---|---|
| 2020-12-31 | -$0.86 10-K · filed 2021-02-18 |
| 2020-09-30 | -$0.63 10-K · filed 2021-02-18 |
| 2020-06-30 | -$0.66 10-K · filed 2021-02-18 |
| 2020-03-31 | -$0.77 10-K · filed 2021-02-18 |
| 2019-12-31 | -$1.41 10-K · filed 2021-02-18 |
| 2019-09-30 | -$8.10 10-K · filed 2021-02-18 |
| 2019-06-30 | -$7.60 10-K · filed 2021-02-18 |
| 2019-03-31 | -$2.66 10-K · filed 2021-02-18 |
| 2018-12-31 | -$2.84 10-K · filed 2020-02-27 |
| 2018-09-30 | -$4.70 10-K · filed 2020-02-27 |
| 2018-06-30 | -$2.07 10-K · filed 2020-02-27 |
| 2018-03-31 | -$2.08 10-K · filed 2020-02-27 |